Brain Health
Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Clinical Trial
Mar 28, 2026 2
Results for "Berberine" in Alzheimer's
20 articles
Brain Health
Nordic Berries Put to the Test for Fighting Age-Related Cognitive Decline
A completed trial tests whether daily Nordic berry beverages can sharpen cognition in healthy adults over 12 weeks.
Clinical Trial
Jun 14, 2026 0
Brain Health
Bioavailable Turmeric Supplement Tested Against Cognitive Decline in Metabolic Syndrome
The EPICURO trial tests MERIVA® turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Clinical Trial
May 7, 2026 0
Brain Health
Retired Cholesterol Drug Shows Promise for Alzheimer's Prevention in Small Trial
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Clinical Trial
Mar 29, 2026 0
Brain Health
Alpha-Lipoic Acid Added to Flunarizine Tested for Teen Migraine Prevention
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
Clinical Trial
Jun 17, 2026 0
Brain Health
Microalgae Supplement BrainPhyt Shows Promise for Cognitive Health in Older Adults
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Clinical Trial
Mar 28, 2026 0
Brain Health
Green Tea Extract Plus Lifestyle Changes Tested Against Cognitive Decline in High-Risk Adults
A completed trial tests EGCG combined with diet, exercise, and cognitive training to slow decline in ApoE4 carriers with early warning signs.
Clinical Trial
May 15, 2026 0
Brain Health
MIND Diet Plus Forest Bathing Shows Promise for Blood Pressure and Brain Health
Combining Mediterranean-DASH diet with nature therapy targets hypertension and cognitive decline in older adults.
Clinical Trial
Mar 28, 2026 1
Brain Health
Antiviral Drug Valacyclovir Tested to Slow Alzheimer's Progression in MCI Patients
A Phase II trial tests whether blocking herpes virus activity can protect against Alzheimer's disease in early cognitive decline.
Clinical Trial
Jun 6, 2026 0
Brain Health
BACE Inhibitor Atabecestat Trial in Pre-Symptomatic Alzheimer's Risk Terminated Early
A phase 2/3 trial of the BACE inhibitor atabecestat in amyloid-positive asymptomatic adults was terminated before completion, raising questions about this drug class.
Clinical Trial
May 13, 2026 0
Brain Health
Dasatinib and Quercetin Reach the Brain in Early Alzheimer's Patients
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
Clinical Trial
May 28, 2026 0
Brain Health
Psilocybin Shows Promise for Treatment-Resistant Depression in Clinical Trial
Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.
Clinical Trial
Mar 28, 2026 1
Brain Health
Psilocybin Shows Promise for Treating Alcohol Addiction in Swiss Clinical Trial
University of Zurich researchers tested psilocybin against placebo in 37 alcohol-dependent patients using rigorous double-blind methodology.
Clinical Trial
Mar 28, 2026 0
Brain Health
Carnosine Supplement Targets Neuromuscular Decline in Multiple Sclerosis
A completed pilot trial tests whether 2g/day of a novel carnosine formulation can restore neuromuscular function and quality of life in MS patients.
Clinical Trial
Jun 17, 2026 0
Brain Health
Psilocybin Plus Therapy Shows Promise for Depression in Completed Clinical Trial
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
Clinical Trial
Mar 28, 2026 0
Brain Health
Hyperbaric Oxygen Therapy Targets Cognition in Diabetic Elderly at Dementia Risk
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
Clinical Trial
Jun 18, 2026 0
Brain Health
New Drug Shows Promise in Preventing Alzheimer's Amyloid Buildup in Young Adults
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
Clinical Trial
Mar 28, 2026 0
Brain Health
Rural Community Program Targets Alzheimer's Risk Through Lifestyle Interventions
Small pilot study tests multicomponent behavioral program to reduce cognitive decline risk in underserved rural populations.
Clinical Trial
Mar 28, 2026 1
Brain Health
Creatine Monohydrate Tested as Bioenergetic Therapy for Alzheimer's Disease
A completed University of Kansas trial investigates whether creatine monohydrate can support brain energy metabolism in Alzheimer's patients.
Clinical Trial
Jun 18, 2026 0
Brain Health
SSRI Antidepressants May Block Psychedelic Effects by Reducing Brain Receptors
Swiss researchers tested whether paroxetine reduces LSD response by downregulating serotonin receptors in healthy adults.
Clinical Trial
Mar 28, 2026 1
Page 1 of 2Next